Cargando…
LINX(®), a novel treatment for patients with refractory asthma complicated by gastroesophageal reflux disease: a case report
BACKGROUND: Gastroesophageal reflux disease is one of the most common comorbidities in patients with asthma. Gastroesophageal reflux disease can be linked to difficult-to-control asthma. Current management includes gastric acid suppression therapy and surgical antireflux procedures. The LINX® proced...
Autores principales: | Sriratanaviriyakul, Narin, Kivler, Celeste, Vidovszky, Tamas J., Yoneda, Ken Y., Kenyon, Nicholas J., Murin, Susan, Louie, Samuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878099/ https://www.ncbi.nlm.nih.gov/pubmed/27220906 http://dx.doi.org/10.1186/s13256-016-0887-6 |
Ejemplares similares
-
Spotlight on the Linx™ Reflux Management System for the treatment of gastroesophageal reflux disease: evidence and research
por: Zadeh, Jonathan, et al.
Publicado: (2018) -
LINX(®) reflux management system to bridge the “treatment gap” in gastroesophageal reflux disease: A systematic review of 35 studies
por: Schizas, Dimitrios, et al.
Publicado: (2020) -
Self-Administered Mepolizumab in the Management of Severe Asthma: Usability and Patient Acceptance
por: Miyokawa, Reika, et al.
Publicado: (2020) -
Refractory gastroesophageal reflux disease
por: Subramanian, Charumathi Raghu, et al.
Publicado: (2015) -
Gastroesophageal Reflux in Children with Asthma
por: Lupu, Vasile Valeriu, et al.
Publicado: (2022)